06/21/2012 - 11:49am

Faced with the possibility of a critical cutoff in funding for the Food and Drug Administration, Congress moved in late May to reauthorize the Prescription Drug User Fee Act that provides the bulk of the agency’s resources for new-drug review and approval. 


06/21/2012 - 11:49am

The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said. Ranbaxy announced the FDA approval of Absorica (isotretinoin), a drug for treating severe recalcitrant nodular acne.

06/21/2012 - 11:47am

While the picture of a new Rx-to-OTC switch paradigm is being painted with a broad stroke brush, already there are two divergent pathways emerging around what that new paradigm landscape might look like. 


06/20/2012 - 11:01am

Pharmacy customers who use the Mscripts application to order, refill and manage their prescriptions now can do so in English or Spanish, the company announced Wednesday.

06/20/2012 - 10:56am

Hamacher Resource Group on Tuesday announced it will present “Marketing Diabetes in the Retail Setting” June 21 at the Marketing Diabetes Prevention and Awareness Conference in Atlanta.

06/19/2012 - 2:37pm

Mylan's Canadian subsidiary has launched a new website that is designed to help Canadians learn more about the value, reliability and quality of generic pharmaceuticals.

06/19/2012 - 11:18am

Maxim Health Systems now is a certified distributor of the Citi Flu Care card, the healthcare group announced Tuesday.

06/19/2012 - 8:21am

The U.S. Court of Appeals for the Federal Circuit ruled in favor of Watson Pharmaceuticals during patent litigation concerning the drug maker's abbreviated new drug application for an overactive bladder treatment.

06/18/2012 - 11:59am

Greenstone, the generic pharmaceutical subsidiary of Pfizer, has launched olanzapine tablets.